6 States Join FTC's Challenge To Amgen's $28B Horizon Buy

By Renee Hickman · June 23, 2023, 6:31 PM EDT

Illinois and California are among six states that have joined the Federal Trade Commission's antitrust suit against Amgen's planned $28 billion purchase of Horizon Therapeutics, the maker of the drug Tepezza...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Federal Trade Commission V. Amgen Inc., et al.

Case Number

1:23-cv-03053

Court

Illinois Northern

Nature of Suit

410(Anti-Trust)

Date Filed

May 16, 2023